metricas
covid
Buscar en
Enfermedades Infecciosas y Microbiología Clínica (English Edition)
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica (English Edition) Oral involvement in mucormycosis. A retrospective study of 55 cases
Journal Information

Statistics

Follow this link to access the full text of the article

Brief report
Oral involvement in mucormycosis. A retrospective study of 55 cases
Mucormicosis con compromiso oral. Estudio retrospectivo de 55 casos
Alexandro Bonifaza,
Corresponding author
a_bonifaz@yahoo.com.mx

Corresponding author.
, Andrés Tirado-Sáncheza, Fernando Paredes-Farrerab, Joaquín Moreno-Morenoc, Javier Araizaa, Gloria M. Gonzálezd
a Dermatology Service, & Mycology Department, Hospital General de México, “Dr. Eduardo Liceaga”, Mexico
b Stomatology Service, Hospital General de México, “Dr. Eduardo Liceaga”, Mexico
c Infectology Service, Hospital General de México, “Dr. Eduardo Liceaga”, Mexico
d Microbiology Department, Universidad Autónoma de Nuevo León, Mexico
Read
544
Times
was read the article
137
Total PDF
407
Total HTML
Share statistics
Article information
ISSN: 2529993X
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 August 5 1 6
2024 July 7 6 13
2024 June 10 3 13
2024 May 18 3 21
2024 April 17 3 20
2024 March 11 8 19
2024 February 13 7 20
2024 January 7 4 11
2023 December 7 4 11
2023 November 13 9 22
2023 October 14 4 18
2023 September 11 2 13
2023 August 7 3 10
2023 July 9 3 12
2023 June 18 2 20
2023 May 35 0 35
2023 April 74 4 78
2023 March 31 4 35
2023 February 9 2 11
2023 January 11 6 17
2022 December 13 7 20
2022 November 12 3 15
2022 October 11 13 24
2022 September 8 6 14
2022 August 9 12 21
2022 July 10 9 19
2022 June 17 9 26
Show all

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos